5^th Annual European Pharma Congress July 18-20, 2016 Berlin,Germany

Anna Szemik-Hojniak has completed her PhD in Radiochemistry from the University of Wroclaw and postdoctoral studies in Physical Chemistry and Radiochemistry from Solvay Fundation (Belgium), KULeuven (Belgium) and Centre of Nuclear Researches (Strasburg, France). She occupies with Organic Molecular Photophysics , published more than 45 papers and serves as a reviewer in scientific journals. In the years (2002-2011) she served as the INWES Board director (2002-2011) for INWES corporation- the operational partner of UNESCO. In 2007, at the University of Wroclaw, (Poland), she organized international workshop “Strategies for the Highly Skilled Global Workforce”. In 2011, Dr Szemik was awarded with Distinguished Service Award. Presently she is INWES-ERI General Secretary and the Board Director (headquarters-Ottawa, Canada).In 2014 and 2015, she organized Mini Symposium “Photophysics of Electron and Proton Transfer” in the framework of ICCMSE- 2014 conference, in Athens (Greece) and presented the Keynote lecture on “Behavior of styryl derivatives under the light irradiation” during 4th-Annual European Pharma Congress-2015 in Valencia (Spain).

Her Research interest is in Time-Resolved Emission Spectroscopy (Excited State Electron and Proton Transfer) of organic compounds for high - tech and Pharmaceutical Industry.

Palanisamy Sivanandy earned his Ph.d from the prestigious Tamil Nadu Dr.MGR Medical University, Chennai and Good Clinical Practice Licensure Exam from Ministry of Health, Malaysia. He has published more than 40 research papers in reputed journals and has been serving as an editorial board member of repute. He has received many grants from Indian Council of Medical Research, New Delhi; Department of Science & Technology, New Delhi; and Centre for International Co-Operation in Science, Chennai; International Medical University, Malaysia, etc.

Molecular mechanisms of autoimmune diseases

Yahdiana harahap has completed her PhD at the age of 39 from Department of Pharmacy, Institute Technology Bandung, Indonesia. Now she is the Head of Biavailability and Bioequivalence laboratory Faculty of Pharmacy, Universitas Indonesia. Prior to this position, she was the Dean of Faculty of Pharmacy, Universitas Indonesia. She has published 40 papers published in both International and National Journals. She has been invited to be the speakers in many international conference, especially in the field of BA/BE and Bioanalysis technique. She currently serves as an expert at Indonesia National Agency of Drug and Food Control, spesifically in BA/BE evaluation.

Bioavailability and Bioequivalence

Adalberto Rezende Santos is Ph.D in Cellular and Molecular Biology from Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Actually, he is a Senior Investigator and Head of the Laboratory of Molecular Biology Applied to Mycobacteria of Oswaldo Cruz Institute, Supervisor at the post-graduation programs of Cellular, Molecular Biology, and Clinical Medicine from Fiocruz and Federal University of Rio de Janeiro respectively. He is ad hoc consultant of the Executive Secretariat of Science Technology and Environment and of the Ministry of Health, Brazil. He is also referee of the Journal of Infectious Diseases and Pharmacogenomics.

Pharmacogenomics

Hulya Ozdemir has completed her PhD in Faculty of Medicine, She is working as a Professor at the Medicine Faculty of Yuzuncu Yıl University. She’s the head of department of Pharmacology and Toxicology. She has published more than 70 papers.

Plant therapy on the diabetes and cancer diseases , antioxidants and behavioural pharmacology.

Ouahab Ammar has completed his PhD at the age of 29 years from China Pharmaceutical University. He is an professor in the department of Pharmacy at Batna University. He has successfully developed a novel oral delivery system of indomethacin for Roche hoffman when he was a master student. He has been active in research on new smart drug delivery systems. and has published 12 papers in reputed journals.

Oral delivery system

Prof. Sinerik Ayrapetyan has completed his Ph.D in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev. He is the head and coordinator of Research Council of Life Sciences International Postgraduate Educational Center, UNESCO Chair, Yerevan, Armenia. His current research interest is “Intracellular Signaling System in Norm and Pathology”. On this subject he has published 7 international books and 115 papers. He is a member of the board of associate editors for the journals: "Electromagnetic Biology and Medicine", "Journal of International Dental and Medical Research", “ISRN Biophysics”, and a member of editorial board of the journals: “Advances in Life Sciences", “Bioavailability and Bioequivalence”, “Applied Pharmacy”, “European Journal of Biophysics”, “Biochimica et Biophysica Acta”. He is a member of International Coordination Council of WHO and number of professional international societies.

“Intracellular Signaling System in Norm and Pathology”

Dr. Moses S S Chow graduated from University of California and currently is Professor of Pharmacy Practice and Director, Center for Advancement of Drug Research and Evaluation (CADRE) at the College of Pharmacy, Western University of Health Sciences, Pomona, California. His previous academic appointments included professor, University of Connecticut School of Pharmacy and Director, Chinese University of Hong Kong. He has supervised/co-supervised over 40 Masters and Ph.D. degree students and post-doctoral fellows. He has published as author/co-author over 300 hundred articles, book chapters, monographs in pharmacokinetic studies, translational research and development of new drugs, including Chinese medicine. He has served as a consultant to NIH and USPs as well as visiting professor to a number of Pharmacy Schools in Asia. He has served as Board member and Secretary of the American College of Clinical Pharmacology, President of American Chinese Pharmaceutical

Personalized medicine for resistant cancer-a potential new role for herbal medicine

Dr. Moses S S Chow graduated from University of California and currently is Professor of Pharmacy Practice and Director, Center for Advancement of Drug Research and Evaluation (CADRE) at the College of Pharmacy, Western University of Health Sciences, Pomona, California. His previous academic appointments included professor, University of Connecticut School of Pharmacy and Director, Chinese University of Hong Kong. He has supervised/co-supervised over 40 Masters and Ph.D. degree students and post-doctoral fellows. He has published as author/co-author over 300 hundred articles, book chapters, monographs in pharmacokinetic studies, translational research and development of new drugs, including Chinese medicine. He has served as a consultant to NIH and USPs as well as visiting professor to a number of Pharmacy Schools in Asia. He has served as Board member and Secretary of the American College of Clinical Pharmacology, President of American Chinese Pharmaceutical

Personalized medicine for resistant cancer-a potential new role for herbal medicine

Irina Ermolina has completed her PhD from Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences in 1995, following by postdoctoral studies from Hebrew University of Jerusalem, Glasgow University and Southhampton University. Currently, she is a senior lecturer at De Montfort University, Leicester, UK, theaching the pharmaceutical technology, pharmaceutical material sciences and analytical techniques. She has published 45 papers in the peer reviewed journals and has been serving as a reviewer for several sceintific Journals

Physicochemical and pharmaceutical properties of HEA-HEMA hydrogels

Dr Pierre Lutgen was born 1940 in Luxembourg, studied at the University of Louvain in Belgium and obtained diplomas in chemistry, social sciences and philosophy. He worked during 25 years for the Dupont Cy, in research, and during 8 years in the steel industry, mainly in the environmental field. Since his retirement he worked as consultant for health and environment as invited professor at the University in Medellin and for the European Communities in several countries. Over the last ten years he has organized the association IFBV-BELHERB studying and fighting tropical diseases with some 30 academic and medical partners in Africa, South America and Europe. Numerous peer reviewed papers have been published by this team, mainly on herbal medicine

Tropical diseases